Abstract
The main objective of this study is to assess the prevalence of sleep disorders in treatment-naïve children and adolescents with ADHD compared with healthy controls matched for age and gender; and, at the same time, to determine whether stimulant medication (methylphenidate) affects sleep in the same group of children and adolescents with ADHD (naïve) after a 3-month treatment. A total of 120 children and adolescents (60 newly diagnosed with ADHD according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM IV), and 60 gender- and age-matched controls) were evaluated through objective (actigraphy) and subjective (sleep diary) measures. Later, of those 60 newly diagnosed with ADHD, 30 started pharmacological treatment with methylphenidate with a mean daily dose of 0.58 mg/kg. No significant differences in both measures within the ADHD group after following the 3-month pharmacological treatment with methylphenidate were found. There were neither any significant differences in sleep parameters through objective measures between the medication-naïve ADHD group and the control group, while significant differences were found through sleep diary (registered by parents) in latency and efficiency (p = < 0.05). These findings suggest that patients receiving a mean daily dose of 0.58 mg/kg of methylphenidate for 3 months did not experience sleep disturbances, based on objective (actigraphy) and subjective data. In addition, sleep problems in ADHD subjects may be overestimated by parents due to ADHD symptomatology.
Similar content being viewed by others
References
Thomas R, Sanders S, Doust J, Beller E, Glaszious P. Prevalence of attention-deficit / hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):e994–1001. https://doi.org/10.1542/peds.2014-3482.
Becker SP, Langberg JM, Evans SW. Sleep problems predict comorbid externalizing behaviors and depression in young adolescents with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2015;24(8):897–907. https://doi.org/10.1007/s00787-014-0636-6.
Mindell JA, Meltzer LJ. Behavioural sleep disorders in children and adolescents. Ann Acad Med Singapore. 2008;37(8):722–8.
Le Cornu F, Dimitriou D. Poor sleep has negative implications for children with and without ADHD, but in different ways. Behav Sleep Med. 2017;17(4):423–36. https://doi.org/10.1080/15402002.2017.1395335.
Sung V, Hiscock H, Sciberras E, Efron D. Sleep problems in children with attention-deficit/hyperactivity disorder: prevalence and the effect on the child and family. Arch Pediatr Adolesc Med. 2008;162(4):336–42. https://doi.org/10.1001/archpedi.162.4.336.
Chamorro M, Lara JP, Insa I, Espadas M, Alda-díez JA. Evaluación y tratamiento de los problemas de sueño en niños diagnosticados de trastorno por déficit de atención/hiperactividad: actualización de la evidencia. Rev Neurol. 2017;64(9):413–21. https://doi.org/10.33588/rn.6409.2016539.
Storebø OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents—assessment of adverse events in non-randomised studies. Cochrane Database Syst Rev. 2018. https://doi.org/10.1002/14651858.CD012069.pub2.
Catalá-López F, Hutton B, Núñez-Beltrán A, Mayhew AD, Page MJ, Ridao M, et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials. Syst Rev. 2015;4(19):1–10. https://doi.org/10.1371/journal.pone.0180355.eCollection.
Cortese S. Are the effects of methylphenidate uncertain? Irish J Psychol Med. 2018;35:163–7. https://doi.org/10.1017/ipm.2018.16.
Steingard R, Taskiran S, Connor DF, Markowitz JS, Stein MA. New formulations of stimulants: an update for clinicians. J Child Adolesc Psychopharmacol. 2019;29(5):324–39. https://doi.org/10.1089/cap.2019.0043.
Catalá-López F, Hutton B. Comment digital health interventions for children with ADHD. Lancet Digit Heal. 2020;7500(20):1–2. https://doi.org/10.1371/journal.pone.0180355.
Chin WC, Huang YS, Chou YH, Wang C-H, Chen K-T, Fu J, et al. Subjective and objective assessments of sleep problems in children with attention deficit/hyperactivity disorder and the effects of methylphenidate treatment. Biomed J. 2018;41(6):356–63. https://doi.org/10.1016/j.bj.2018.10.004.
Cohen-Zion M, Ancoli-Israel S. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies. Sleep Med Rev. 2004;8(5):379–402. https://doi.org/10.1016/j.smrv.2004.06.002.
Kosse RC, Bouvy ML, Philbert D, de Vries TW, Koster ES. Attention-deficit/hyperactivity disorder medication use in adolescents: the patient’s perspective. J Adolesc Heal. 2017;61(5):619–25. https://doi.org/10.1016/j.jadohealth.2017.05.027.
Clavenna A, Bonati M. Pediatric pharmacoepidemiology—safety and effectiveness of medicines for ADHD. Expert Opin Drug Saf. 2017;16(12):1335–45. https://doi.org/10.1080/14740338.2017.1389894.
Caye A, Swanson JM, Coghill D, Rohde LA. Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. Mol Psychiatry. 2018;24(3):390–408. https://doi.org/10.1038/s41380-018-0116-3.
Ricketts EJ, Sturm A, McMakin DL, McGuire JF, Tan PZ, Smalberg FB, et al. Changes in sleep problems across Attention-deficit/hyperactivity disorder treatment: findings from the multimodal treatment of attention-deficit/hyperactivity disorder study. J Child Adolesc Psychopharmacol. 2018;28(10):690–8. https://doi.org/10.1089/cap.2018.0038.
Stuckert G, O’Laughlin L, Brubaker B. Attention Deficit Hyperactivity Disorder and sleep disturbances: consideration of parental influence. Behav Sleep Med. 2012;10(1):41–53. https://doi.org/10.1080/15402002.2012.636274.
Stein MA, Weiss M, Hlavaty L. ADHD Treatments, sleep, and sleep problems: Complex associations. Neurotherapeutics. 2012;9(3):509–17. https://doi.org/10.1007/s11920-017-0860-0.
Huang Y-S, Tsai M-H, Guilleminault C. Pharmacological treatment of ADHD and the short and long term effects on sleep. Curr Pharm Des. 2011;17(15):1450–8. https://doi.org/10.2174/138161211796197179.
Corkum P, Tannock R, Moldofsky H, Hogg-Johnson S, Humphries T. Actigraphy and parental ratings of sleep in children with ADHD. Pediatr Sleep. 2001;24(3):303. https://doi.org/10.1093/sleep/24.3.303.
Corkum P, Panton R, Ironside S, MachPherson M, Williams T. Response: acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder. J Pediatr Psychol. 2007;34(1):110–2. https://doi.org/10.1093/jpepsy/jsn109.
Pliszka SR, Wilens TE, Bostrom S, Arnold VK, Marraffino A, Cutler AJ, et al. Efficacy and safety of HLD200, delayed-release and extended-release methylphenidate, in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2017;27(6):474–82. https://doi.org/10.1089/cap.2017.0084.
Wechsler D. WISC-IV: escala de inteligencia de wechsler para Niños-IV. Madrid: TEA Ediciones; 2005.
Soutullo C. Traducción al Español de la Entrevista Diagnóstica: Kiddie-schedule for affective disorders and schizophrenia, present and lifetime version (K-SADS-PL, 1996). 1996. https://www.cun.es/dam/cun/archivos/pdf/psiquiatria-psicologia-medica/KSADSEsp.pdf.
DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD rating scale—IV: checklists, norms, and clinical interpretation. New York: The Guilford Press; 1998.
Conners C, Sitarenios G, Parker J, Epstein J. The revised Conners’ parent rating scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol. 1998;26(4):257–68.
Achenbach TM, Rescorla L. Manual for the ASEBA school-age forms & profiles. Burlington: University of Vermont, Research Center for Children, Youth, & Families; 2001.
Bergwerff C, Luman M, Oosterlaan J. No objectively measured sleep disturbances in children with attention-deficit/hyperactivity disorder. J Sleep Res. 2016;25(5):534–40. https://doi.org/10.1111/jsr.12399.
Owens J, Sangal R, Sutton V, Bakken R. Subjective and objective measures of sleep in children with attention-deficit/hyperactivity disorder. Sleep Med. 2009;10(4):446–56. https://doi.org/10.1016/j.sleep.2008.03.013.
Solleveld MM, Schrantee A, Baek HK, Bottelier MA, Tamminga HGH, Bouziane C, et al. Effects of 16 weeks of methylphenidate treatment on actigraph-assessed sleep measures in medication-naive children with ADHD. Front Psychiatry. 2020;11(February):1–9. https://doi.org/10.3389/fpsyt.2020.00082.
Corkum P, Begum EA, Rusak B, Rajda M, Shea S, Macpherson M, et al. The effects of extended-release stimulant medication on sleep in children with ADHD. J Can Acad Child Adolesc Psychiatry. 2020;29(1):33–43.
Poirier A, Corkum P. Night-to-night variability of sleep in children with ADHD and typically developing controls. J Atten Disord. 2018;22(10):942–6. https://doi.org/10.1177/1087054715575065.
Chaput J-P. Sleep patterns, diet quality and energy balance. Physiol Behav. 2013. https://doi.org/10.1016/j.physbeh.2013.09.006.
Acknowledgements
We thank Dr. Serrano for her help in collecting the material. We also would like to thanks all the patients and families for their cooperation.
Funding
All phases of this study were supported by Grant PI11/2009 from the Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Spain.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical approval
This study was approved by the Clinical Research Ethics Committee (CEIC) of Fundació Sant Joan de Déu with permission number: CEIC PIC-17-11 and was conducted following the ethical principles of the Declaration of Helsinki.
Research involving human participants
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sanabra, M., Gómez-Hinojosa, T., Alcover, C. et al. Effects of stimulant treatment on sleep in attention deficit hyperactivity disorder (ADHD). Sleep Biol. Rhythms 19, 69–77 (2021). https://doi.org/10.1007/s41105-020-00289-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41105-020-00289-3